APLLTD Stock View

Alembic Pharmaceuticals Ltd

APLLTD Stock View

(NSE)

Trade

₹ 790.75

-10.75 | -1.36

Market Cap ₹( Cr.)
155,432.30

Proj. P/E (x)
30.16

Proj. P/BV (x)
3.30

Proj. ROE (%)
11.40

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
63,008.12

HOLD

Last Updated On.
01-Oct-2023

 

Copy Link

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data